Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02216227 · ClinicalTrials.gov registry record · NA
Checklist to Prevent MRSA Surgical Site Infections
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 23,005
- Enrollment target
NCT02216227: Completed NA study, sponsored by VA Office of Research and Development.
NCT02216227 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 23,005 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1540% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02216227, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 23,005 participants
- Enrollment target
Study Summary
The goals of this project are 1) to assess the effectiveness and cost-effectiveness of the checklist to prevent MRSA SSIs among Veterans undergoing TJA or cardiac surgery, and 2) to assess barriers and facilitators to checklist implementation. Hypotheses: 1. The SSI checklist will be effective at reducing MRSA SSIs among total joint arthroplasty and cardiac surgery patients. 2. Implementation of the checklist will be associated with an overall reduction in SSIs caused by all pathogens. 3. The SSI Checklist will be cost-saving since it will prevent many expensive SSIs. 4. Preoperative MRSA testing will be a modifiable barrier to implementing the SSI checklist.
Primary Outcome
Participants with superficial and deep/organ space MRSA infections, 90 days postoperatively, as measured by VA electronic health data.
Interventions
- DRUG Vancomycin
- DRUG Cefazolin
- DRUG Mupirocin
- DRUG Chlorhexidine gluconate
- DRUG Nasal Povidone Iodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,005 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
What the finished NCT02216227 record still lists
NCT02216227 is an interventional study that assigns participants to a tested intervention. Its 23,005 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1540% higher).
The record links to 0 conditions, and to 5 interventions - of which Vancomycin is the first listed.
NCT02216227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02216227 about?
NCT02216227 is a clinical study titled "Checklist to Prevent MRSA Surgical Site Infections". The goals of this project are 1) to assess the effectiveness and cost-effectiveness of the checklist to prevent MRSA SSIs among Veterans undergoing TJA or cardiac surgery, and 2) to assess barriers and facilitators to checklist implementation. Hypotheses: 1. The SSI checklist will be effective at ...
What is the current status of trial NCT02216227?
This trial is currently completed. It is a NA study. The enrollment target is 23,005 participants. The study started on 2014-04-01. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT02216227?
The interventions under investigation include: Vancomycin (DRUG), Cefazolin (DRUG), Mupirocin (DRUG), Chlorhexidine gluconate (DRUG), Nasal Povidone Iodine (DRUG).
Who is sponsoring clinical trial NCT02216227?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02216227's enrollment target sits among peer trials
23,005 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06486688 · 22,320 participants · NA
Centralized Virtual SBIRT for Pediatric Primary Care
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI